Market capitalization | $7.08b |
Enterprise Value | $6.94b |
P/E (TTM) P/E ratio | 16.70 |
EV/FCF (TTM) EV/FCF | 17.59 |
EV/Sales (TTM) EV/Sales | 4.83 |
P/S ratio (TTM) P/S ratio | 4.92 |
P/B ratio (TTM) P/B ratio | 7.03 |
Revenue growth (TTM) Revenue growth | 27.83% |
Revenue (TTM) Revenue | $1.44b |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
12 Analysts have issued a Lantheus Holdings Inc forecast:
12 Analysts have issued a Lantheus Holdings Inc forecast:
Jun '24 |
+/-
%
|
||
Revenue | 1,438 1,438 |
28%
28%
|
|
Gross Profit | 927 927 |
27%
27%
|
|
EBITDA | 512 512 |
133%
133%
|
EBIT (Operating Income) EBIT | 453 453 |
173%
173%
|
Net Profit | 428 428 |
1,184%
1,184%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.
Head office | United States |
CEO | Brian Markison |
Employees | 834 |
Founded | 1956 |
Website | www.lantheus.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.